In a follow up study, the Diastolic Heart Failure Anakinra Response Trial-2 (DHART-2), patients with stable symptomatic HFpEF were treated with Anakinra to confirm the effects on peak VO2 and CRP and observe its effects on serum NT-proBNP (46). Here, CRP is linked to diastolic heart failure.